Marie Daghlian

Writer, editor, researcher: I communicate the innovation and business trends of biotech to diverse audiences

[Big4Bio @big4bio]

#RESI2023 is in full-swing and we're excited to announce @BioStartupNews’ partnership with @LSciNation! Coming this July 2023, produced by Life Science Nation and BigBio Communications, BioStartup News will change to LifeSci Startup. #RESIBOS #BIO2023

[Big4Bio @big4bio]

We're excited to update this incredible FREE resource and bring subscribers more tools in this fast-paced and exciting industry. If you're attending #RESI2023, visit our table to subscribe, or sign up here: https://t.co/VZnE3d5EsO @LSciNation #RESI #RESIBOS #BIO2023

[Big4Bio @big4bio]

Our weekly U.S.-based life science newsletter will become a DAILY newsletter with up-to-date press releases, financial news, tools, and more for and about industry startups and founders. #LifeSciences #BIO2023 #Startups #Biotech

[Marie Daghlian @mdaghbio]

Share https://t.co/VwnBhIDu6B

[Marie Daghlian @mdaghbio]

Diversity, equity, inclusion - check out #Big4Bio and #KMA Pivot Report https://t.co/ZuMRzypXqm

[Marie Daghlian @mdaghbio]

Everything #JPM - Big4Bio On Your Mark 2022 just published https://t.co/CXJsWhUHRg

[DealForma @DealForma]

Biopharma deals set records in 2020 that 2021 is primed to beat. Here's a look back from @mdaghbio and @ChrisDoko Go #biotech #pharma #partnerships ! https://t.co/ZNBO5goSzM

[Marie Daghlian @mdaghbio]

Dealforma crunches 2020 M&A: numbers up values down
https://t.co/vuyAGzKj0i

[Marie Daghlian @mdaghbio]

@Gates and @GV back @Cerevance target discovery platform https://t.co/0oU5ohOnFQ

[Marie Daghlian @mdaghbio]

GigaGen Focuses Its Technology to Address COVID-19 Pandemic #COVID-19 https://t.co/LwvwtFjNNW

[Marie Daghlian @mdaghbio]

And as Big4Bio-area life science organizations work to provide solutions and therapies for the betterment of mankind, the Big4Bio:PHP gives these life science employers a tool to help their own employees have the best health outcomes possible. https://t.co/yzJYv1n2rS

[Daniel S. Levine @dslevine]

.@TaniaSimoncelli @ChanZuckerberg discusses the organization’s Rare As One program designed to help rare disease organization accelerate efforts to develop treatments for their conditions on @GlobalGenes #RARECast. https://t.co/x8KzyQCfJc

[DealForma @DealForma]

A decade of biopharma reverse mergers here:

https://t.co/KpHKe3Jhfy

[DealForma @DealForma]

Gene therapy R&D deals turn red hot as Big Pharma steps up to play - https://t.co/v2oNjJsxRi

[Marie Daghlian @mdaghbio]

Emil Kakkis receives Henri Termeer Biotech Visionary Award @BIO2019

[Marie Daghlian @mdaghbio]

Life Sciences M&A Starts with a Bang in 2019 after Rebounding in 2018 | @DealForma Biotech Database - Deals, Venture, Pipelines, Sales Data https://t.co/4NdHsWZOtU

[Marie Daghlian @mdaghbio]

Spotlight: What Small and Emerging Companies Need When Entering Into Dealmaking Discussions https://t.co/8kCx814e6J

[Marie Daghlian @mdaghbio]

@BIO2018

[Marie Daghlian @mdaghbio]

Patientory: Making Healthcare Secure with Blockchain https://t.co/kpXzRdPPHD chain-Marie-Daghlian/?published=t

[Marie Daghlian @mdaghbio]

Patientory: Making Healthcare Secure with Blockchain https://t.co/hk4lmAKxeS